"By the time Torin died, some very promising research had already begun on a promising new organic replacement tissue. The research continued after his death, though the financial strain was tremendous. Last year we were finally ready to go into production, but access to the market was virtually blocked. Tavis’s only chance to save NuGene and his family was to get as many Portland backers as he could, promising to set up a branch of NuGene in Seattle. Tavis himself underwent a transplant treatment on his injured knee, using our new tissue. It worked wonderfully, but he was waiting until his position in Seattle was established before announcing it. Things seemed to be going fine until the raid on the Sapphire Seahawk . Tavis had no choice but to go public with the stock in hopes of making enough profit that he could buy it all back at a later date, or at least maintain a controlling interest. We had to go into production immediately before someone else beat us to it. But the cost overruns on moving so fast have been incredible."